Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
KANTARJIAN, HAGOP M
One or more keywords matched the following items that are connected to KANTARJIAN, HAGOP M
Item TypeName
Concept Interleukin-7 Receptor alpha Subunit
Concept Interleukin-3 Receptor alpha Subunit
Academic Article SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia.
Academic Article Interleukin-7 receptor-a gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.
Academic Article Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.
Academic Article CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Academic Article Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.
Academic Article Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.
Academic Article North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Academic Article Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023.
Academic Article Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.
Academic Article Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Search Criteria
  • Interleukin 7 Receptor alpha Subunit